Geminin predicts adverse clinical outcome in breast cancer by reflecting cell-cycle progression. | Profiles RNS

RCMI Coordinating Center (RCMI CC)

Geminin predicts adverse clinical outcome in breast cancer by reflecting cell-cycle progression.

Gonzalez MA, Tachibana KE, Chin SF, Callagy G, Madine MA, Vowler SL, Pinder SE, Laskey RA, Coleman N. Geminin predicts adverse clinical outcome in breast cancer by reflecting cell-cycle progression. J Pathol. 2004 Oct; 204(2):121-30.

View in: PubMed

authors with profiles

Michael J Gonzalez

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support